{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:02:10Z","timestamp":1780048930419,"version":"3.53.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,26]],"date-time":"2013-07-26T00:00:00Z","timestamp":1374796800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s10157-013-0838-0","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T15:31:57Z","timestamp":1374766317000},"page":"41-49","source":"Crossref","is-referenced-by-count":41,"title":["Current topics in therapeutic plasmapheresis"],"prefix":"10.1007","volume":"18","author":[{"given":"Takeshi","family":"Nakanishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kuragano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Hasuike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,26]]},"reference":[{"key":"838_CR1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1537-2995.1971.tb04383.x","volume":"11","author":"RG Graw Jr","year":"1971","unstructured":"Graw RG Jr, Herzig GP, Eisel RJ, Perry S. Leukocyte and platelet collection from normal donors with the continuous flow blood cell separator. Transfusion. 1971;11:94\u2013101.","journal-title":"Transfusion"},{"key":"838_CR2","first-page":"273","volume":"9","author":"A Li\u00e9geois","year":"1977","unstructured":"Li\u00e9geois A, Escourrou J, Ouvr\u00e9 E, Charreire J. Microchimerism: a stable state of low-ratio proliferation of allogeneic bone marrow. Transplant Proc. 1977;9:273\u20136.","journal-title":"Transplant Proc"},{"key":"838_CR3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1744-9987.1997.tb00012.x","volume":"1","author":"A Sueoka","year":"1997","unstructured":"Sueoka A. Present status of apheresis technologies: part 1. Membrane plasma separator. Ther Apher. 1997;1:42\u20138.","journal-title":"Ther Apher"},{"key":"838_CR4","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.ajkd.2008.02.360","volume":"52","author":"AA Kaplan","year":"2008","unstructured":"Kaplan AA. Therapeutic plasma exchange: core curriculum 2008. Am J Kidney Dis. 2008;52:1180\u201396.","journal-title":"Am J Kidney Dis"},{"key":"838_CR5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jca.20240","volume":"25","author":"ZM Szczepiorkowski","year":"2010","unstructured":"Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Apheresis Applications Committee of the American Society for Apheresis, et al. Guidelines on the use of therapeutic apheresis in clinical practice\u2013evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher. 2010;25:83\u2013177.","journal-title":"J Clin Apher"},{"key":"838_CR6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000181222","volume":"20","author":"M Fuss","year":"1978","unstructured":"Fuss M, Bagon J, Dupont E, Manderlier T, Brauman H, Corvilain J. Parathyroid hormone and calcium blood levels in acute renal failure. With special reference to one patient developing transient hypercalcemia. Nephron. 1978;20:196\u2013202.","journal-title":"Nephron"},{"key":"838_CR7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jca.10041","volume":"17","author":"ME Brecher","year":"2002","unstructured":"Brecher ME. Plasma exchange: why we do what we do. J Clin Apher. 2002;17:207\u201311.","journal-title":"J Clin Apher"},{"key":"838_CR8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jca.20250","volume":"25","author":"RA Balogun","year":"2010","unstructured":"Balogun RA, Ogunniyi A, Sanford K, Okafor C, Lobo PI, Siami G, Barcia J, Kaplan AA. Therapeutic apheresis in special populations. J Clin Apher. 2010;25:265\u201374.","journal-title":"J Clin Apher"},{"key":"838_CR9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.beha.2005.01.004","volume":"19","author":"BC McLeod","year":"2006","unstructured":"McLeod BC. Therapeutic apheresis: use of human serum albumin, fresh frozen plasma and cryosupernatant plasma in therapeutic plasma exchange. Best Pract Res Clin Haematol. 2006;19:157\u201367.","journal-title":"Best Pract Res Clin Haematol"},{"key":"838_CR10","first-page":"71","volume-title":"Apheresis principles and practice","author":"KP Crookston","year":"2003","unstructured":"Crookston KP, Simon TL. Physiology of apheresis. In: McLeod BC, editor. Apheresis principles and practice. Bethesda: AABB Press; 2003. p. 71\u201393."},{"key":"838_CR11","first-page":"13","volume-title":"Therapeutic Hemapheresis","author":"M Chopek","year":"1980","unstructured":"Chopek M, McCullough J. Protein and biochemical changes during plasma exchange. In: Berkman EM, Umlas J, editors. Therapeutic Hemapheresis. Washington, DC: American Association of Blood Banks; 1980. p. 13\u201352."},{"key":"838_CR12","first-page":"295","volume-title":"Apheresis: principles and practice","author":"R Weinstein","year":"2003","unstructured":"Weinstein R. Basic priciples pf therapeutic Blood exchange. In: Mcleod BC, Price TH, Weinstein R, editors. Apheresis: principles and practice. 2nd ed. Bethesda: AABB Press; 2003. p. 295\u2013320.","edition":"2"},{"key":"838_CR13","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1537-2995.2005.04312.x","volume":"45","author":"S Haddad","year":"2005","unstructured":"Haddad S, Leitman SF, Wesley RA, Cecco S, Yau YY, Starling J, Rehak NN, Bolan CD. Placebo-controlled study of intravenous magnesium supplementation during large-volume leukapheresis in healthy allogeneic donors. Transfusion. 2005;45:934\u201344.","journal-title":"Transfusion"},{"key":"838_CR14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","volume":"347","author":"JL Moake","year":"2002","unstructured":"Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002;347:589\u2013600.","journal-title":"N Engl J Med"},{"key":"838_CR15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2169\/internalmedicine.49.2706","volume":"49","author":"Y Fujimura","year":"2010","unstructured":"Fujimura Y, Matsumoto M. Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998\u20132008. Intern Med. 2010;49:7\u201315.","journal-title":"Intern Med"},{"key":"838_CR16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM199108083250605","volume":"325","author":"WR Bell","year":"1991","unstructured":"Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med. 1991;325:398\u2013403.","journal-title":"N Engl J Med"},{"key":"838_CR17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","volume":"325","author":"GA Rock","year":"1991","unstructured":"Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med. 1991;325:393\u20137.","journal-title":"N Engl J Med"},{"key":"838_CR18","unstructured":"Bruce C, McLeod MD. Therapeutic plasma exchange. In: Winters JL, editor. Therapeutic apheresis: a physicians\u2019s handbook. 2nd ed. Bathesda: American Society for Apheresis (ASFA); 2008. p. 69\u2013134."},{"key":"838_CR19","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1378\/chest.08-1071","volume":"134","author":"RT Stravitz","year":"2008","unstructured":"Stravitz RT. Critical management decisions in patients with acute liver failure. Chest. 2008;134:1092\u2013102.","journal-title":"Chest"},{"key":"838_CR20","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1572-0241.2001.03706.x","volume":"96","author":"JO Clemmesen","year":"2001","unstructured":"Clemmesen JO, Kondrup J, Nielsen LB, Larsen FS, Ott P. Effects of high-volume plasmapheresis on ammonia, urea, and amino acids in patients with acute liver failure. Am J Gastroenterol. 2001;96:1217\u201323.","journal-title":"Am J Gastroenterol"},{"key":"838_CR21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1177\/039139880002300708","volume":"23","author":"G Silvestro De","year":"2000","unstructured":"De Silvestro G, Marson P, Brandolese R, Pittoni G, Ongaro G. A single institution\u2019s experience (1982\u20131999) with plasma-exchange therapy in patients with fulminant hepatic failure. Int J Artif Organs. 2000;23:454\u201361.","journal-title":"Int J Artif Organs"},{"key":"838_CR22","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00000658-200109000-00015","volume":"234","author":"AL Singer","year":"2001","unstructured":"Singer AL, Olthoff KM, Kim H, Rand E, Zamir G, Shaked A. Role of plasmapheresis in the management of acute hepatic failure in children. Ann Surg. 2001;234:418\u201324.","journal-title":"Ann Surg"},{"key":"838_CR23","first-page":"406","volume":"26","author":"T Agishi","year":"1980","unstructured":"Agishi T, Kaneko I, Hasuo Y, Hayasaka Y, Sanaka T, Ota K, et al. Double filtration plasmapheresis. Trans Am Soc Artif Intern Organs. 1980;26:406\u201311.","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"838_CR24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1526-0968.2002.00428.x","volume":"6","author":"M Mineshima","year":"2002","unstructured":"Mineshima M, Akiba T. Double filtration plasmapheresis in critical care. Ther Apher. 2002;6:180\u20133.","journal-title":"Ther Apher"},{"key":"838_CR25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1744-9987.1997.tb00029.x","volume":"1","author":"A Sueoka","year":"1997","unstructured":"Sueoka A. Present status of apheresis technologies: part 2. Membrane plasma fractionator. Ther Apher. 1997;1:135\u201346.","journal-title":"Ther Apher"},{"key":"838_CR26","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ncpneph0967","volume":"4","author":"N Ichimaru","year":"2008","unstructured":"Ichimaru N, Takahara S. Japan\u2019s experience with living-donor kidney transplantation across ABO barriers. Nat Clin Pract Nephrol. 2008;4:682\u201392.","journal-title":"Nat Clin Pract Nephrol"},{"key":"838_CR27","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1177\/039139880502801010","volume":"28","author":"F Morelli","year":"2005","unstructured":"Morelli F, Carlier P, Giannini G, De Luigi MC, Dejana AM, Ruzzenenti MR. Hypercholesterolemia and LDL apheresis. Int J Artif Organs. 2005;28:1025\u201331.","journal-title":"Int J Artif Organs"},{"key":"838_CR28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.transci.2004.01.008","volume":"30","author":"R Klingel","year":"2004","unstructured":"Klingel R, Mausfeld P, Fassbender C, Goehlen B. Lipidfiltration\u2013safe and effective methodology to perform lipid-apheresis. Transfus Apher Sci. 2004;30:245\u201354.","journal-title":"Transfus Apher Sci"},{"key":"838_CR29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1526-0968.2000.004004275.x","volume":"4","author":"AP Batocchi","year":"2000","unstructured":"Batocchi AP, Evoli A, Di Schino C, Tonali P. Therapeutic apheresis in myasthenia gravis. Ther Apher. 2000;4:275\u20139.","journal-title":"Ther Apher"},{"key":"838_CR30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-510X(03)00031-5","volume":"210","author":"N Inoue","year":"2003","unstructured":"Inoue N, Kunishige M, Yoshida S, Oshima Y, Ohnishi Y, Kuroda Y, et al. Dissociation between titer of anti-ganglioside antibody and severity of symptoms in a case of Guillain-Barr\u00e9 syndrome with treatment-related fluctuation. J Neurol Sci. 2003;210:105\u20138.","journal-title":"J Neurol Sci"},{"key":"838_CR31","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/00007890-200011150-00011","volume":"70","author":"H Shimmura","year":"2000","unstructured":"Shimmura H, Tanabe K, Ishikawa N, Tokumoto T, Takahashi K, Toma H. Role of anti-A\/B antibody titers in results of ABO-incompatible kidney transplantation. Transplantation. 2000;70:1331\u20135.","journal-title":"Transplantation"},{"key":"838_CR32","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/01.tp.0000173647.43616.78","volume":"80","author":"H Shimmura","year":"2005","unstructured":"Shimmura H, Tanabe K, Ishida H, Tokumoto T, Ishikawa N, Miyamoto N, et al. Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression. Transplantation. 2005;80:985\u20138.","journal-title":"Transplantation"},{"key":"838_CR33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1526-0968.2003.00010.x","volume":"7","author":"N Hirata","year":"2003","unstructured":"Hirata N, Kuriyama T, Yamawaki N. Immusorba TR and PH. Ther Apher Dial. 2003;7:85\u201390.","journal-title":"Ther Apher Dial"},{"key":"838_CR34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1526-0968.2003.00018.x","volume":"7","author":"T Asahi","year":"2003","unstructured":"Asahi T, Yamamoto T, Kutsuki H. Blood purification therapies using dextran sulfate cellulose columns Liposorber and Selesorb. Ther Apher Dial. 2003;7:73\u20137.","journal-title":"Ther Apher Dial"},{"key":"838_CR35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1525-1594.2004.29007.x","volume":"29","author":"DH Krieter","year":"2005","unstructured":"Krieter DH, Steinke J, Kerkhoff M, Fink E, Lemke HD, Zingler C, M\u00fcller GA, Schuff-Werner P. Contact activation in low-density lipoprotein apheresis systems. Artif Organs. 2005;29:47\u201352.","journal-title":"Artif Organs"},{"key":"838_CR36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1537-2995.1994.341095026976.x","volume":"34","author":"HG Owen","year":"1994","unstructured":"Owen HG, Brecher ME. Atypical reactions associated with use of angiotensin-converting enzyme inhibitors and apheresis. Transfusion. 1994;34:891\u20134.","journal-title":"Transfusion"},{"key":"838_CR37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1744-9987.1997.tb00045.x","volume":"1","author":"S Kojima","year":"1997","unstructured":"Kojima S, Harada-Shiba M, Yamamoto A. Plasma constituents other than low-density lipoprotein adsorbed by dextran-sulfate column. Ther Apher. 1997;1:309\u201313.","journal-title":"Ther Apher"},{"key":"838_CR38","first-page":"83","volume-title":"Comparison of protein A- and tryptophan-conjugated polyvinyl alcohol gel columns with an anti-human immunoglobulin antibody adsorber. Current advances in therapeutic plasmapheresis","author":"C Jim\u00e9nez-Klingberg","year":"1996","unstructured":"Jim\u00e9nez-Klingberg C, Borberg H. Comparison of protein A- and tryptophan-conjugated polyvinyl alcohol gel columns with an anti-human immunoglobulin antibody adsorber. Current advances in therapeutic plasmapheresis. London: Churchill Livingstone; 1996. p. 83\u201393."},{"key":"838_CR39","first-page":"82","volume":"67","author":"A R\u00f8dgaard","year":"1987","unstructured":"R\u00f8dgaard A, Nielsen FC, Djurup R, Somnier F, Gammeltoft S. Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3. Clin Exp Immunol. 1987;67:82\u20138.","journal-title":"Clin Exp Immunol"},{"key":"838_CR40","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","volume":"55","author":"J McConville","year":"2004","unstructured":"McConville J, Farrugia ME, Beeson D, Kishore U, Metcalfe R, Newsom-Davis J, Vincent A. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol. 2004;55:580\u20134.","journal-title":"Ann Neurol"},{"key":"838_CR41","first-page":"318","volume":"28","author":"Z Yamazaki","year":"1982","unstructured":"Yamazaki Z, Fujimori Y, Takahama T, Inoue N, Wada T, Kazama M, Morioka M, Abe T, Yamawaki N, Inagaki K. Efficiency and biocompatibility of a new immunosorbent. Trans Am Soc Artif Intern Organs. 1982;28:318\u201323.","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"838_CR42","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1744-9987.1998.tb00126.x","volume":"2","author":"Y Tsuboi","year":"1998","unstructured":"Tsuboi Y, Takahashi M, Ishikawa Y, Okada H, Yamada T. Elevated bradykinin and decreased carboxypeptidase R as a cause of hypotension during tryptophan column immunoabsorption therapy. Ther Apher. 1998;2:297\u20139.","journal-title":"Ther Apher"},{"key":"838_CR43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jca.20298","volume":"26","author":"K Gwathmey","year":"2011","unstructured":"Gwathmey K, Balogun RA, Burns T. Neurologic indications for therapeutic plasma exchange: an update. J Clin Apher. 2011;26:261\u20138.","journal-title":"J Clin Apher"},{"key":"838_CR44","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/archneur.63.8.1066","volume":"63","author":"HC Lehmann","year":"2006","unstructured":"Lehmann HC, Hartung HP, Hetzel GR, St\u00fcve O, Kieseier BC. Plasma exchange in neuroimmunological disorders: part 2. Treatment of neuromuscular disorders. Arch Neurol. 2006;63:1066\u201371.","journal-title":"Arch Neurol"},{"key":"838_CR45","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","volume":"119","author":"AF Hahn","year":"1996","unstructured":"Hahn AF, Bolton CF, Pillay N, Chalk C, Benstead T, Bril V, Shumak K, Vandervoort MK, Feasby TE. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study. Brain. 1996;119:1055\u201366.","journal-title":"Brain"},{"key":"838_CR46","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198602203140801","volume":"314","author":"PJ Dyck","year":"1986","unstructured":"Dyck PJ, Daube J, O\u2019Brien P, Pineda A, Low PA, Windebank AJ, Swanson C. Plasmaexchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med. 1986;314:461\u20135.","journal-title":"N Engl J Med"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-013-0838-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-013-0838-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-013-0838-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T12:02:25Z","timestamp":1563537745000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-013-0838-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,26]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["838"],"URL":"https:\/\/doi.org\/10.1007\/s10157-013-0838-0","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,26]]}}}